Many treatments are available, and with the popularity of online and mail-order services in recent years, two leaders are BlueChew and Hims. Both companies offer different ED treatments and a ...

Here. A healthcare provider can help diagnose the cause of ED and recommend appropriate treatment. it was already two months later. New erectile dysfunction treatments in 2024, such as those offered ...

Hims and Roman are two online ED treatment options that offer convenient and discreet access to medications and supplements. They both offer online consultations and medication delivery, but they have ...

ED can affect anyone with a penis, regardless of their gender identity. Hims is a telemedicine platform that allows you to connect with medical professionals who can diagnose and prescribe ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Hims & Hers generated $1.5 billion in revenue in 2024, reflecting a 69% year-over-year increase. See why I rate HIMS stock a ...

The stock price of Hims & Hers Health (NYSE: HIMS), a telehealth platform, has risen a stellar 43% in a week. Much of this move came after the company’s controversial Super Bowl commercial ...

With the FDA shutting down its key revenue stream, Hims faces a tough road ahead--can it justify its valuation?

Hims & Hers delivered Q4 2024 earnings that saw the stock sell off nearly 20% after hours. Find out why I rate HIMS stock a buy.

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions ...

Telehealth stock Hims & Hers (HIMS) spiked more than 24% in trading Thursday, days after its Super Bowl ad promoting cheaper GLP-1 weight-loss drugs sparked controversy. The ad criticized the American ...

Shares of Hims & Hers Health (NYSE: HIMS) sank 10.5% this week, according to data from S&P Global Market Intelligence. The telehealth company that sells dermatology, sexual health, and weight loss ...